Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 90 clinical trials
Multiparametric Assessment of Bone Response in mCRPC Patients Treated With Cabozantinib (MERIDIAN)

Multiparametric assesment of bone response in mCRPC patients treated with Cabozantinib upon progression to chemotherapy and next generation hormonal agents: a phase II study

Accepts healthy volunteers
  • 0 views
  • 06 Mar, 2022
  • 1 location
Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases (CABRAMET)

This is a multicenter, open-label, exploratory, single-arm, prospective phase II study to assess the efficacy and safety profile of cabozantinib in patients with brain metastases from metastatic

metastasis
brain metastases
cabozantinib
neutrophil count
  • 2 views
  • 21 Feb, 2022
  • 4 locations
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

This is a phase 2 single-arm, open-label clinical trial determining efficacy of cabozantinib in combination with ipilimumab/nivolumab and transarterial chemoembolization (TACE) in subjects with

nivolumab
measurable disease
neutrophil count
tubal ligation
TACE
  • 0 views
  • 19 Apr, 2022
  • 1 location
A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3 (CABONEN)

The main objective of this clinical trial represents the evaluation of efficacy of the tyrosine kinase inhibitor Cabozantinib in patients with NEN G3 with a proliferation rate of Ki67 20 - 60

cabozantinib
ki-67
progressive disease
  • 0 views
  • 07 Oct, 2022
  • 9 locations
Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors

This phase I trial finds the best dose and side effects of cabozantinib and pamiparib in treating patients with solid tumors that have spread to other places in the body (advanced) or does not

  • 0 views
  • 04 Oct, 2022
  • 1 location
Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities

This phase I/II trial studies the side effects and best dose of cabozantinib when given with radiation therapy and how well it works in treating patients with sarcoma of the extremities

  • 0 views
  • 04 Oct, 2022
  • 1 location
Study of CAbozantinib in Combination With AtezolizumaB for Muscle-Invasive BladdEr Cancer (ABATE)

This is an open-label phase II study assessing the activity of cabozantinib combined with atezolizumab in patients with resectable muscle-invasive urothelial carcinoma who are ineligible for

metastasis
gilbert's syndrome
carcinoma
neutrophil count
cancer
  • 0 views
  • 07 Oct, 2022
  • 5 locations
Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma

This is a phase 2 single-arm, open-label clinical trial determining efficacy of cabozantinib in combination with pembrolizumab in subjects with advanced gastric and gastroesophageal

tubal ligation
neutrophil count
pembrolizumab
taxane
metastatic cancer
  • 8 views
  • 21 Apr, 2022
  • 1 location
Dose Escalation Study of Cabozantinib for Advanced HCC Patients With Preserved Liver Function

Open-label, single arm, multicenter phase II trial assessing the tolerability of a reduced starting dose of 40 mg cabozantinib for 4 weeks and subsequent dose escalation to 60 mg cabozantinib

cabozantinib
progressive disease
  • 0 views
  • 26 Apr, 2022
  • 8 locations
Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer

Data from a prior phase II study of single agent cabozantinib in metastatic, refractory colorectal cancer (NCT03542877) combined with the compelling preclinical data in colorectal mouse models

VEGFR2
monoclonal antibodies
  • 0 views
  • 08 Dec, 2021
  • 5 locations